Accuracy of Screening for Inhalational Anthrax after a Bioterrorist Attack

Annals of Internal Medicine

Volumn 139, Issue 5 I, 2003, Pages

  Hupert, Nathaniel ^a   Bearman, Gonzalo M L ^a   Mushlin, Alvin I ^a   Callahan, Mark A ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAX; BIOLOGICAL WARFARE; CLINICAL FEATURE; COUGHING; DIAGNOSTIC ACCURACY; FEVER; HUMAN; INHALATIONAL ANTHRAX; LUNG AUSCULTATION; LUNG AUSCULTATION ABNORMALITY; MASS SCREENING; NAUSEA; NEUROLOGIC DISEASE; OUTPATIENT; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; REVIEW; RHINORRHEA; SORE THROAT; VIRUS INFECTION; VOMITING; ARTICLE; CLINICAL PROTOCOL; CONFUSION; DIFFERENTIAL DIAGNOSIS; DYSPNEA; STANDARD; UNCONSCIOUSNESS;

ANTHRAX; BIOTERRORISM; CLINICAL PROTOCOLS; CONFUSION; DIAGNOSIS, DIFFERENTIAL; DYSPNEA; HUMANS; MASS SCREENING; NAUSEA; RESPIRATORY TRACT INFECTIONS; UNCONSCIOUSNESS; VIRUS DISEASES; VOMITING;

EID: 1642535485     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-139-5_part_1-200309020-00009     Document Type: Review

References (55)

1. Gerbercling JL, Hughes JM, Koplan JP. Bioterrorism preparedness and response: clinicians and public health agencies as essential partners [Editorial]. JAMA. 2002;287:898-900. [PMID: 11851584]
2. Recognition of illness associated with the intentional release of a biologic agent. MMWR Morb Mortal Wkly Rep. 2001;50:893-7. [PMID: 11686473]
3. Borio L, Frank D, Mani V, Chiriboga C, Pollanen M, Ripple M, et al. Death due to bioterrorism-related inhalational anthrax: report of 2 patients. JAMA. 2001;286:2554-9. [PMID: 11722269]
4. Jernigan JA, Stephens DS, Ashford DA, Omenaca C, Topiel MS, Galbraith M, et al. Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg Infect Dis. 2001;7:933-44. [PMID: I1747719]
5. Swartz MN. Recognition and management of anthrax - an update. N Engl J Med. 2001;345:1621-6. [PMID: 11704686]
6. Inglesby TV, O'Toole T, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, et al. Anthrax as a biological weapon, 2002: updated recommendations for management. JAMA. 2002;287:2236-52. [PMID: 11980524]
7. Shafazand S, Doyle R, Ruoss S, Weinacker A, Raffin TA. Inhalational anthrax: epidemiology, diagnosis, and management. Chest. 1999;116:1369-76. [PMID: 10559102]
8. Khan AS, Morse S, Lillibridge S. Public-health preparedness for biological terrorism in the USA. Lancet. 2000;356:1179-82. [PMID: 11030310]
9. Hupert N, Mushlin AI, Callahan MA. Modeling the public health response to bioterrorism: using discrete event simulation to design antibiotic distribution centers. Med Decis Making. 2002;22:S17-25. [PMID: 12369227]
10. Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001. MMWR Morb Morral Wlky Rep. 2001;50:909-19. [PMID: 11699843]
11. Bartlett JG, Inglesby TV Jr, Borio L. Management of anthrax. Clin Infect Dis. 2002;35:851-8. [PMID: 12228822]
12. Brookmeyer R, Blades N. Prevention of inhalational anthrax in the U.S. outbreak. Science. 2002;295:1861. [PMID: 11884746]
13. Kaufmann AF, Meltzer MI, Schmid GP. The economic impact of a bioterrorist attack: are prevention and postattack intervention programs justifiable? Emerg Infect Dis. 1997;3:83-94. [PMID: 9204289]
14. Bloem K. Treating the sick: capacity of the US Health Care System to respond to an epidemic. Public Health Rep. 2001;116 Suppl 2:34-5. [PMID: 11880668]
15. Considerations for distinguishing influenza-like illness from inhalational anthrax. MMWR Morb Mortal Wlky Rep. 2001;50:984-6. [PMID: 11724153]
16. Vlahov D, Galea S, Frankel D. New York City, 2001: reaction and response [Editorial]. J Urban Health. 2002;79:2-5. [PMID: 11937606]
17. Barakat LA, Quentzel HL, Jernigan JA, Kirschke DL, Griffith K, Spear SM, et al. Fatal inhalational anthrax in a 94-year-old Connecticut woman. JAMA. 2002;287:863-8. [PMID: 11851578]
18. Mina B, Dym JP, Kuepper F, Tso R, Arrastia C, Kaplounova I, et al. Fatal inhalational anthrax with unknown source of exposure in a 61 year-old woman in New York City. JAMA. 2002;287:858-62. [PMID: 11851577]
19. Mayer TA, Bersoff-Matcha S, Murphy C, Earls J, Harper S, Pauze D, et al. Clinical presentation of inhalational anthrax following bioterrorism exposure: report of 2 surviving patients. JAMA. 2001;286:2549-53. [PMID: 11722268]
20. Update: Investigation of bioterrorism-related anthrax - Connecticut, 2001. MMWR Morb Mortal Wlky Rep. 2001;50:1077-9. [PMID: 11770501]
21. LaForce FM, Bumford FH, Feeley JC, Stokes SL, Snow DB. Epidemiologic study of a fatal case of inhalation anthrax. Arch Environ Health. 1969;18:798-805. [PMID: 4976545]
22. Severn M. A fatal case of pulmonary anthrax. Br Med J. 1976;1:748. [PMID: 1260311]
23. Suffin SC, Carnes WH, Kaufmann AF. Inhalation anthrax in a home craftsman. Hum Pathol. 1978;9:594-7. [PMID: 101438]
24. Vessal K, Yeganehdoust J, Dutz W, Kohout E. Radiological changes in inhalation anthrax. A report of radiological and pathological correlation in two cases. Clin Radiol. 1975;26:471-4. [PMID: 811421]
25. Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Friedlander AM, et al. Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA. 1999;281:1735-45. [PMID: 10328075]
26. Brooksher W, Briggs J. Pulmonary anthrax: report of a case. JAMA. 1920;74:323-4.
27. Cabot Case Records, Case 14032: An acute infection with bloody fluid in the right pleural sac. N Engl J Med. 1928;198:148-50.
28. Cowdery J. Primary pulmonary anthrax with septicemia. Arch Pathol. 1947;43:396-99.
29. Haight T. Anthrax meningitis: review of the literature and report of two cases with autopsies. Am J Med Sci. 1952;224:57-69.
30. Gold H. Anthrax: a report of one hundred seventeen cases. AMA Archives of Internal Medicine. 1955;96:387-96.
31. Plotkin SA, Brachman PS, Utell M, Bumford FH, Atchison MM. An epidemic of inhalation anthrax, the first in the twentieth century: I. Clinical features. 1960. Am J Med. 2002;112:4-12; discussion 2-3. [PMID: 11812400]
32. Brachman PS, Pagano JS, Albrink WS. Two cases of fatal inhalation anthrax, one associated with sarcoidosis. N Engl J Med. 1961;265:203-8.
33. Hall CB. Respiratory syncytial virus and parainfluenza virus. N Engl J Med. 2001;344:1917-28. [PMID: 11419430]
34. Carrat F, Tachet A, Rouzioux C, Housset B, Valieron AJ. Evaluation of clinical case definitions of influenza: detailed investigation of patients during the 1995-1996 epidemic in France. Clin Infect Dis. 1999;28:283-90. [PMID: 10064245]
35. Monto AS, Gravenstein S, Elliott M, Colopy M, Schweinle J. Clinical signs and symptoms predicting influenza infection. Arch Intern Med. 2000;160:3243-7. [PMID: 11088084]
36. Hall CB, Long CE, Schnabel KC. Respiratory syncytial virus infections in previously healthy working adults. Clin Infect Dis. 2001;33:792-6. [PMID: 11512084]
37. van Elden LJ, van Essen GA, Boucher CA, van Loon AM, Nijhuis M, Schipper P, et al. Clinical diagnosis of influenza virus infection: evaluation of diagnostic tools in general practice. Br J Gen Pract. 2001;51:630-4. [PMID: 11510391]
38. Oliveira EC, Marik PE, Colice G. Influenza pneumonia: a descriptive study. Chest. 2001;119:1717-23. [PMID: 11399696]
39. Govaert TM, Dinant GJ, Aretz K, Knottnerus JA. The predictive value of influenza symptomatology in elderly people. Fam Pract. 1998;15:16-22. [PMID: 9527293]
40. Boivin G, Hardy I, Tellier G, Maziade J. Predicting influenza infections during epidemics with use of a clinical case definition. Clin Infect Dis. 2000;31:1166-9. [PMID: 11073747]
41. Fine AD, Bridges CB, De Guzman AM, Glover L, Zeller B, Wong SJ, et al. Influenza A among patients with human immunodeficiency virus: an outbreak of infection at a residential facility in New York City. Clin Infect Dis. 2001;32:1784-91. [PMID: 11360221]
42. Church DL, Davies HD, Mitton C, Semeniuk H, Logue M, Maxwell C, et al. Clinical and economic evaluation of rapid influenza a virus testing in nursing homes in Calgary, Canada. Clin Infect Dis. 2002;34:790-5. [PMID: 11830797]
43. Zambon M, Hays J, Webster A, Newman R, Keene O. Diagnosis of influenza in the community: relationship of clinical diagnosis to confirmed virological, serologic, or molecular detection of influenza. Arch Intern Med. 2001;161:2116-22. [PMID: 11570941]
44. Marrie TJ, Peeling RW, Fine MJ, Singer DE, Coley CM, Kapoor WN. Ambulatory patients with community-acquired pneumonia: the frequency of atypical agents and clinical course. Am J Med. 1996;101:508-15. [PMID: 8948274]
45. Goodman SN. Toward evidence-based medical statistics. 2: The Bayes factor. Ann Intern Med. 1999;130:1005-13. [PMID: 10383350]
46. Metlay JP, Schulz R, Li YH, Singer DE, Marrie TJ, Coley CM, et al. Influence of age on symptoms at presentation in patients with community-acquired pneumonia. Arch Intern Med. 1997;157:1453-9. [PMID: 9224224]
47. Sackett DL, Straus SE, Richardson WS, Rosenberg W, Haynes RB. Evidence-Based Medicine: How To Practice and Teach EBM. 2nd ed. Edinburgh, United Kingdom: Churchill Livingstone; 2000.
48. Moolenaar RL, Dalton C, Lipman HB, Umland ET, Gallaher M, Duchin JS, et al. Clinical features that differentiate hantavirus pulmonary syndrome from three other acute respiratory illnesses. Clin Infect Dis. 1995;21:643-9. [PMID: 8527558]
49. Lijmer JG, Mol BW, Heisterkamp S, Bonsel GJ, Prins MH, van der Meulen JH, et al. Empirical evidence of design-related bias in studies of diagnostic tests. JAMA. 1999;282:1061-6. [PMID: 10493205]
50. Metlay JP, Fine MJ. Testing strategies in the initial management of patients with community-acquired pneumonia. Ann Intern Med. 2003;138:109-18. [PMID: 12529093]
51. Kuehnert MJ, Doyle TJ, Hill HA, Bridges CB, Jernigan JA, Dull PM, et al. Clinical features that discriminate inhalational anthrax from other acute respiratory illnesses. Clin Infect Dis. 2003;36:328-36. [PMID: 12539075]
52. Meselson M, Guillemin J, Hugh-Jones M, Langmuir A, Popova I, Shelokov A, et al. The Sverdlovsk anthrax outbreak of 1979. Science. 1994;266:1202-8. [PMID: 7973702]
53. Grinberg LM, Abramova FA, Yampolskaya OV, Walker DH, Smith JH. Quantitative pathology of inhalational anthrax I: quantitative microscopic findings. Mod Pathol. 2001;14:482-95. [PMID: 11353060]
54. Yang QK. [A clinico-radiographic analysis of 8 cases of pulmonary anthrax (author's transl)]. Zhonghua Fang She Xue Za Zhi. 1979;13:242-3. [PMID: 162416]
55. National Institutes of Health, Office of Public Health Preparedness, Centers for Disease Control and Prevention. Optimizing post-exposure prevention of inhalational anthrax: issues and options. Washington, DC: National Academy of Sciences; 2001.